Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
5.46M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
221K
-
Shares change
-
+47.4K
-
Total reported value, excl. options
-
$398K
-
Value change
-
-$11.3K
-
Put/Call ratio
-
0.15
-
Number of buys
-
8
-
Number of sells
-
-9
-
Price
-
$1.80
Significant Holders of 180 Life Sciences Corp. - Common Stock, $0.0001 par value (ATNF) as of Q1 2023
21 filings reported holding ATNF - 180 Life Sciences Corp. - Common Stock, $0.0001 par value as of Q1 2023.
180 Life Sciences Corp. - Common Stock, $0.0001 par value (ATNF) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 221K shares
of 5.46M outstanding shares and own 4.04% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (115K shares), CITADEL ADVISORS LLC (23.9K shares), Cubist Systematic Strategies, LLC (23.5K shares), VANGUARD GROUP INC (15.8K shares), BlackRock Inc. (15K shares), TWO SIGMA INVESTMENTS, LP (14.1K shares), GEODE CAPITAL MANAGEMENT, LLC (10.6K shares), Tower Research Capital LLC (TRC) (2.3K shares), MORGAN STANLEY (738 shares), and Level Financial Advisors, Inc. (100 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.